Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction

This study has been withdrawn prior to enrollment.
(lack of funding)
Sponsor:
Collaborator:
Allergan
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
NCT01272414
First received: January 6, 2011
Last updated: June 2, 2015
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: February 2012
  Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)